Binge Eating Disorder Therapeutic Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Binge Eating Disorder Therapeutic Market is segmented By Drug Class (Anticonvulsant, Antidepressant, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned.
Competitive overview of Binge Eating Disorder Therapeutic Market
The major players operating in the Binge Eating Disorder Therapeutic Market include Tryp Therapeutics, AstraZeneca plc, Sun Pharmaceutical Industries Ltd, Chronos Therapeutics, Shire US Inc., Eli Lilly and Company, Sunovion Pharmaceuticals Inc., Sorrento Therapeutics, Inc., Johnson & Johnson and Lupin Limited.
Binge Eating Disorder Therapeutic Market Leaders
- Tryp Therapeutics
- AstraZeneca plc
- Sun Pharmaceutical Industries Ltd
- Chronos Therapeutics
- Shire US Inc.
*Disclaimer: Major players are listed in no particular order.
Binge Eating Disorder Therapeutic Market - Competitive Rivalry, 2023
Binge Eating Disorder Therapeutic Market
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights